Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Cancer. 2020 May 26;126(15):3464–3470. doi: 10.1002/cncr.32964

TABLE 2.

Treatment-Related Adverse Events (n = 39)

Toxicity All Grades, No. (%) Grade ≥ 3, No. (%)

Fatigue 23 (59) 4 (10.3)
Hypertension 21 (53.8) 12 (30.8)
AST increased 20 (51.3) 4 (10.3)
ALT increased 17 (43.6) 4 (10.3)
Thrombocytopenia 15 (38.5) 2 (5.1)
Hand foot skin reaction 14 (35.9) 4 (10.3)
Anemia 12 (30.8) 2 (5.1)
Nausea 12 (30.8) 1 (2.6)
Vomiting 9 (23.1) 0
Diarrhea 6 (15.4) 0
Rash, acneiform 3 (7.7) 0
Thromboembolic event 2 (5.1) 2 (5.1)

Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase.